Menu

Mistakes Sunk Research Ship

Investigators say human error caused a Taiwanese research vessel to drift off course and sink last year, claiming the lives of two aboard.

Mar 30, 2015
Kerry Grens

PIXABAY, UNSPLASHTaiwan’s Maritime and Port Bureau has concluded that mistakes by crewmembers contributed to a research vessel veering off course and sinking in October 2014. Two researchers aboard died in the accident.

“The committee members had thorough discussions from both the technical and legal perspectives, and they reached the unanimous conclusion that the accident was caused by personnel errors,” Chi Wen-jong, the director of the Maritime and Port Bureau, told the Taipei Times. “They also reached a consensus on the punishment to be handed down to the individuals responsible.”

A full report on the incident and the crewmembers’ punishment is yet to be released. According to the news report, those responsible could lose their seafaring licenses.

The Ocean Researcher V had turned toward shore a day into its expedition because of rough weather, but altered course, hitting a reef and sinking. Those aboard were rescued, except for Hsu Shuh-chieh, the chief scientist, and Lin I-chun.

“The ship should be equipped with devices to let both the captain and chief officer know they have deviated from the route, which they should have the ability to adjust,” Chi said. “The fact of the matter is none of them did anything to address the problem.”

Science Insider reported that the Taiwan Ocean Research Institute plans to build a replacement vessel.

 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!